Monolitum Flas 15 mg & 30 mg ODT - PPI - Rx

Monolitum Flas 15 mg & 30 mg ODT - PPI - Rx
Product Description

Monolitum Flas 15mg / 30mg - ODT formulation - Pack of 14, 28, 56 orally disintegrating tablets

Monolitum Flas 30mg - Acute treatment of duodenal ulcer, gastric ulcer and oesophagitis due to gastro-oesophageal reflux. Eradication of Helicobacter pylori in patients with duodenal ulcer and benign gastric ulcer in combination with appropriate antibiotics 


Monolitum Flas 15mg - Maintenance for oesophagitis due to gastro-oesophageal reflux

Read more Show less

Laboratorios Salvat, S.A.

  • ES
  • 2016
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Spain
More specifications Fewer specifications
Sales Markets
Show more Show less

Laboratorios Salvat, S.A.

  • ES
  • 2016
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Laboratorios Salvat, S.A. (21)

  • Relive® - Day & Night eye drops - MD

    Product Relive® - Day & Night eye drops - MD

    RELIVE® DRY EYE - 8 Hours of Dry Eye Relief
    RELIVE® NIGHT - 12 Hours of Long-lasting Dry Eye Relief • Preservative-Free • Phosphate-Free • Single-dose vials, very Convenient format
  • Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Product Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Unique combination "ciprofloxacin 3 mg + Fluocinolone 0.25 mg" topical solution 

    Indication: Acute otitis externa and acute otitis media with perforated eardrums in adults and pediatric patients. 
    Dosage regimen: B.I.D x 7 days
    Presentation of multi-dose 10 ml and unit dose vials (14...
  • Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Product Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Fluocinolone acetonide, topical solution. Ekzem is indicated for the treatment of otic eczema in adults. Demonstrated efficacy and safety in clinical studies 
    Available in unit dose vials of 0.4 ml each. (30 vials x box)
  • Cristalmina® - Antiseptic - OTC

    Product Cristalmina® - Antiseptic - OTC

    Chlorhexidine digluconate 1% Cristalmina®, offers a quick action and long-lasting effect.
    Cristalmina®, the antiseptic leader in the Spanish market, is the most complete, for the whole family 

    Indication: Minor skin wounds and burns, even for the umbilical cord in newborns.
  • Cetraxal® Otico 2mg/ml - AOE - Otic solution Rx

    Product Cetraxal® Otico 2mg/ml - AOE - Otic solution Rx

    Ciprofloxacin 3 mg, topical solution. 

    Indication: AOE 
    Dosage:  B.I.D x 7 days.
    Presentation: Available in multidose 10ml  and unit dose vials (15 vials).
  • Cetraflux 3 mg/ml - Eye infection - single-dose vials eye drops - Rx

    Product Cetraflux 3 mg/ml - Eye infection - single-dose vials eye drops - Rx

    Cetraflux 3 mg/ml eye drop solution is indicated for the local treatment of the following infections caused by strains sensitive to ciprofloxacin, in adults, neonates (0-27 days), infants (aged 28 days to 23 months), children (aged 2-11 years), adolescents (aged 12-16 years). Available in single dose conta...
  • Urosens range - Urinary infections - FS

    Product Urosens range - Urinary infections - FS

    "The most complete range for each type of cystitis"

    Urosens: MAINTENANCE in occasional urinary infections.
    Urosens forte: ADJUVANT in urinary infectionsUrosens mannose: MAINTENANCE & ADJUVANT in urinary infections, very recurrent urinary infection
  • Nurane retina - AMD - FS

    Product Nurane retina - AMD - FS

    A sufficient dietary intake of the nutrients contained in Nurane Retina, supplemented when necessary, aids the correct functioning of the retina. Lutein and zeaxanthin are two carotenoids with antioxidant properties which help protect our bodies from attack by free radicals. They have the following functio...
  • Nutira range - Lactose intolerance - FS

    Product Nutira range - Lactose intolerance - FS

    Enables better digestion of dairy products. It helps break down lactose into its two constitutive elements (galactose and glucose) and prevents intestinal symptoms related to lactose intolerance (pain, abdominal swelling, meteorism and diarrhoea) from appearing after the consumption of any dairy product, p...
  • Malacur

    Product Malacur

    Dihydroartemisinin. Piperaquine Phosphate. Malaria


  • Tebarat® 0.5ml/ml - Allergic conjunctivities - single-dose vials eye drops - Rx

    Product Tebarat® 0.5ml/ml - Allergic conjunctivities - single-dose vials eye drops - Rx

    Tebarat® is azelastine 0.05% is indicated for the prevention and the treatment of allergic conjunctivitis. Eye drp presented in single-dose vials, preservative-free.



  • SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    Product SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    SVT-15473 is the first strongest ophthalmic corticosteroid formulated in nanoemulsion (nanodroplets below ~30nm), using IMPACT-SVT®, a patented drug delivery technology, and in single-dose vials, using Blow-Fill-Seal technology packaging.

    SVT-15473 has&nbs...
show all 21 other products

Laboratorios Salvat, S.A. resources (2)

  • Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular

    News Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular

    • Los ensayos clínicos fase III realizados en adultos confirman la eficacia y el excelente perfil de seguridad de SVT-15473 clobetasol oftálmico, formulado con IMPACT-SVT® tecnología patentada de nanoemulsiones, para el tratamiento de la inflamación y el dolor después de una cirugía ocular.
    • Es el primer estudio clínico que se realiza en paciente pediátrico con un corticoide tópico oftálmico en toda Europa.
    • Con el nuevo estudio que se inicia ahora y que se llevará a cabo en seis hospitales españoles se espera demostrar también su seguridad en pacientes pediátricos de 0 a 3 años.
    • Con este proyecto, que ha supuesto una inversión global de más de 20 millones de euros, Laboratorios Salvat da un paso más en su estrategia de afianzarse como un actor clave en el área de oftalmología a nivel internacional.
    10 Jul 2023
  • SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.

    IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.

    2023-11-22